Windlas Biotech Schedules Q2 & H1FY27 Earnings Conference Call
Windlas Biotech Ltd 路 Intimation 路 06 Nov 2026, 11:30 am
Windlas Biotech Schedules Q2 & H1FY27 Earnings Conference Call Windlas Biotech Limited will host an earnings conference call on 6th Nov'26 at 11:30 AM IST to discuss its financial performance for the quarter and half-year ended 30th Sep'26 (Q2 & H1FY27). The call will feature key management representatives, including Managing Director Hitesh Windlass and CEO & CFO Komal Gupta. Primary domestic dial-in numbers include +91 22 6280 1256 and +91 22 7115 8157, alongside international toll-free options for key global regions.
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript 路 13 Nov 2026
- Recording of Conference Call 路 07 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" 路 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. 路 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. 路 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, 路 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
